Context Although glycated hemoglobin A1c is currently the best parameter used clinically to
assess risk for the development of diabetes complications, it does not provide insight into …

The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well
established in improving glycemic control and reducing hypoglycemia. Type 2 diabetes …

Methods| The sampling, laboratory, and analytic methods were identical to those in the
studies conducted in 2020. 2, 3 Plasma samples with complete donor demographic data …

Digital health interventions have been shown to be clinically-effective for type 2 diabetes
mellitus (T2DM) and hypertension prevention and treatment. This study synthesizes and …

Background Mobile health (mHealth) services can not give full play to their value if only it is
used in the short term, and their continuous usage can achieve better effects in health …

Introduction Diabetes is a chronic metabolic disease characterized by high levels of blood
glucose, which can lead over time to severe impairment to the heart, blood vessels, eyes …

Introduction Many patients with type 2 diabetes mellitus (T2DM) suffer from complications
that impose substantial burdens on prognosis and medical costs. Accumulating evidence …

Background: There is plenty of evidence supporting the clinical benefits of mHealth
interventions for type 2 diabetes, but despite often being promoted as cost-effective or cost …

Introduction Telemedicine programs using health technological innovation to remotely
monitor the lifestyles of patients with type 2 diabetes (T2D) can improve glycaemic control …

Background Blood glucose stability has recently been considered important in the treatment
of diabetes. Both hypoglycemia and hyperglycemia can frequently occur in patients with …